Request password
September 28, 2016
Industry consolidation, major new brand launches, and a series of mergers and acquisitions in the U.S. OTC market have caused OTC cost structures to shift both in the near- and long-term. The costs associated with marketing, sales, and promotions of OTC brands tend to have wider swings from year to year, offset by administrative and R&D costs tend to be more stable over time. During this live webinar, Laura Mahecha, Kline’s Healthcare Industry Manager, will reveal key findings from our just published OTC Drugs: U.S. Competitor Cost Structures report which provides the profitability of the 11 leading OTC companies’ OTC units and the top three OTC product classes of each company profiled.
